Centagen Project Director
Bryant Villeponteau, Ph.D., has been active in the field of biotechnology for over twenty years. He has 30 years of scientific leadership experience and about 60 journal and patent publications and holds a B.A. in Economics, a M.A. from the School of Public Health, and a Ph.D. in Molecular Biology from UCLA. He was Assistant Research Chemist in the Department of Chemistry and Biochemistry at UCLA for 4 years and Assistant Professor of Biological Chemistry at the University of Michigan Medical School for 6 years. He then led a research group at Geron Corporation for 4.5 years, where he was the lead inventor in cloning human telomerase, thereby winning the Distinguished Inventor Award for the 2nd best US patent of 1997. As the Champion of Telomerase Therapeutics, he also worked on human stem cells, pioneered by Geron in the 90s. Dr. Villeponteau is currently Chief Scientist at Centagen, which is a pioneer in adult stem cell therapeutics.